Susquehanna International Group, LLP Ab Cellera Biologics Inc. Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$2.39 - $3.49 $92,732 - $135,412	-38,800 Reduced 28.89%	95,500 $247,000
Q2 2024 Aug 15, 2024	SELL	$2.73 - $4.73 $78,897 - $136,697	-28,900 Reduced 17.71%	134,300 $397,000
Q1 2024 May 07, 2024	SELL	$4.29 - $5.97 $77,649 - $108,057	-18,100 Reduced 9.98%	163,200 $739,000
Q4 2023 Feb 14, 2024	BUY	$3.91 - $5.93 $132,158 - $200,434	33,800 Added 22.92%	181,300 $1.04 Million
Q3 2023 Nov 14, 2023	SELL	$4.6 - $7.95 $365,700 - $632,025	-79,500 Reduced 35.02%	147,500 $678,000
Q2 2023 Aug 11, 2023	BUY	$5.66 - $7.59 $554,114 - $743,061	97,900 Added 75.83%	227,000 $1.47 Million
Q1 2023 May 16, 2023	SELL	$7.31 - $11.18 $701,029 - $1.07 Million	-95,900 Reduced 42.62%	129,100 $973,000
Q4 2022 Feb 14, 2023	BUY	$9.48 - $14.52 $942,312 - $1.44 Million	99,400 Added 79.14%	225,000 $2.28 Million
Q3 2022 Nov 14, 2022	SELL	$9.2 - $13.68 $181,240 - $269,496	-19,700 Reduced 13.56%	125,600 $1.24 Million

155

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $841M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.